From Casetext: Smarter Legal Research

Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Co.

United States District Court, Southern District of New York
Jun 28, 2021
Civil Action 21-CV-1025 (PGG)(SLC) (S.D.N.Y. Jun. 28, 2021)

Opinion

Civil Action 21-CV-1025 (PGG)(SLC)

06-28-2021

PRIMED PHARMACEUTICALS, LLC., Plaintiff, v. STARR INDEMNITY & LIABILITY COMPANY, Defendant.


STIPULATED PROTECTIVE ORDER

ECF CASE

WHEREAS, Primed Pharmaceuticals, LLC. (“Primed” or “Plaintiff”) and Starr Indemnity & Liability Company (“Starr” or Defendant”) which are parties to this action request that this Court issue a protective order pursuant to Federal Rule of Civil Procedure 26(c) to protect the confidentiality of nonpublic and competitively sensitive information that each may need to disclose in connection with discovery in this action (hereinafter “the Action”);

WHEREAS Primed and Starr shall be referred to collectively as the “Parties” and individually a “Party”; and

WHEREAS, this Court finds that good cause exists for issuance of an appropriately tailored confidentiality order governing the pretrial phase of the Action;

IT IS HEREBY ORDERED that any person subject to this Order, including without limitation Primed and Starr (including each of their respective corporate parents, affiliated entities, successors, and assigns), their representatives, agents, experts and consultants, all third parties providing discovery in this Action, and all other interested persons with actual or constructive notice of this Order will adhere to the following terms, upon pain of contempt:

1. If any Party or person who provides or has provided Discovery Material in connection with this Action (the “Producing Party”) determines in good faith that such Discovery Material contains or discloses proprietary or non-public information of a commercially, financially or personally sensitive nature such as confidential trade secrets, unpublished financial data, confidential business or products plans, or confidential customer information, or that it would pose a high risk of competitive harm, the Producing Party may designate specifically identified Discovery Material as “CONFIDENTIAL” (such material hereinafter referred to as “Confidential Discovery Material”) or “AEO/ATTORNEYS' EYES ONLY-HIGHLY CONFIDENTIAL” (such material hereinafter referred to as “AEO Highly Confidential Discovery Material.”) For purposes of this Stipulation and Order, both Confidential Discovery Material and AEO Highly Confidential Discovery Material shall be referred to collectively as “Confidential Information, ” and all copies, abstracts, excerpts, analyses or other writings that contain, reflect, reveal or otherwise disclose such Confidential Information shall be handled in strict accordance with the terms of this Stipulation and Order.

2. Copies and/or originals of Confidential Information that are produced, given or exchanged in connection with this Action shall be designated as such by the Producing Party by stamping or otherwise clearly marking at least on the first page of a document or writing “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL.” When the designation is intended to apply to only a portion of a document or writing, that portion shall be clearly marked “CONFIDENTIAL” OR “AEO HIGHLY CONFIDENTIAL.”

3. Information contained or revealed in a deposition, whether in a question, answer, or exhibit, in connection with this Action may be designated on the record as “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL.” Transcripts of testimony and/or exhibits so designated during the deposition may, at the option of any Party, be appropriately marked and bound separately. A Party may also designate information disclosed at depositions as “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL” by notifying counsel for all Parties, in writing, within five (5) days of receipt of the transcript of the deposition of the specific pages and lines of the transcript and/or exhibits which contain Confidential Information. All depositions and the exhibits thereto shall be treated in their entirety as AEO Highly Confidential Discovery Material for a period of five (5) days after receipt by counsel to the deponent of a transcript. Nothing in this paragraph precludes a deponent from reviewing the entirety of his or her transcript and exhibits thereto at any time.

4. The disclosure of Discovery Material without designating it as “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL” in accordance with Paragraphs 1 or 2 does not constitute a waiver of such right and may be corrected by supplemental written notice at any time, with the effect that such Discovery Material will be deemed Confidential Discovery Material or AEO Highly Confidential Discovery Material from the time it is designated “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL.” Upon receipt of such a supplemental designation, any party receiving such Discovery Material (the “Receiving Party”) that disclosed the Discovery Material prior to its designation as Confidential Information shall exercise its best efforts to ensure that the Discovery Material, and any information derived therefrom, is treated as Confidential Information in accordance with the terms of this Stipulation and Order.

5. Except as modified by Paragraph 7 herein with respect to “AEO HIGHLY CONFIDENTIAL” documents and information, Confidential Discovery Material designated “CONFIDENTIAL” shall not be disclosed directly or indirectly by a Receiving Party to persons other than:

a. Parties;
b. Counsel, regular and temporary employees and service vendors of such counsel (including outside copying services and outside litigation support services) for use in accordance with this Stipulation and Order;
c. Outside experts or consultants engaged to assist outside counsel retained specifically for this Action, subject to the conditions and procedures listed in Paragraph 6;
d. Witnesses or deponents and their counsel, during the course of, or to the extent necessary to prepare for, depositions or testimony, subject to the conditions and procedures listed in Paragraph 6 if not otherwise included in this Paragraph 5;
e. Any person indicated on the face of a document to be the author, addressee, or an actual or intended receiving party of the document;
f. Stenographers engaged to transcribe depositions conducted with respect to this Action;
g. The Court and any appellate court and their support personnel; and/or h. The employees and outside attorneys of Starr who have a legitimate business interest in reviewing, evaluating and accessing such designated documents for purposes of litigating and settling this Action provided such person(s) executes a Non-Disclosure Agreement attached hereto as Exhibit A;
i. Any private mediators utilized in the Action, provided such person(s) executes a Non-Disclosure Agreement attached hereto as Exhibit A; and/or j. Any other person upon order of the Court or with the written consent of the Producing Party.

6. All persons listed in Paragraphs 5(c) and 5(d) above, who are given access to Confidential Information or documents or documents containing Confidential Information, therein, shall first execute a Non-Disclosure Agreement in the form annexed as Exhibit A hereto (the “Agreement”), agreeing in writing to be bound by the terms and conditions of this Stipulation and Order, consenting to the jurisdiction of the Court solely for purposes of enforcement of the terms of this Stipulation and Order, and agreeing not to disclose or use any Confidential Discovery

Material for purposes other than those permitted herein. Signed Agreements shall be maintained by counsel for the party responsible for obtaining those Agreements as a condition to giving such persons access to Confidential Discovery Material. Notwithstanding Paragraphs 5(c) and 5(d) above, Confidential Discovery Material may be provided to experts or consultants only to the extent necessary for such expert or consultant to prepare a written opinion, to prepare to testify, or to assist outside counsel retained specifically for this Action, and provided that such expert or consultant is using said materials solely for such purposes.

7. A heightened level of protection will be afforded to Confidential Information designated as “AEO HIGHLY CONFIDENTIAL”

a. A designation of “AEO HIGHLY CONFIDENTIAL” may be made by any producing or designated party only after such party has made a good faith determination that the information or documents include or constitute confidential and proprietary information which, if disclosed to the other party, rather than to his, or its counsel, could result in injury or harm to the designated party's interests, including but not limited to documents or information containing or referring to trade secrets or other confidential and/or proprietary information, technical research, design documents and business or financial information.
b. Information or documents designated as “AEO HIGHLY CONFIDENTIAL” may only be disclosed to outside counsel of record, the persons identified in 5(b)-(j) and persons employed by Primed and Starr who have a legitimate business interest in reviewing, evaluating and accessing such designated documents for purposes of litigating and settling this Action. . The Parties agree that the person to whom the “AEO HIGHLY CONFIDENTIAL” information or document is disclosed will not use such information of documents received from the Producing Party for competitive purposes, including but not limited to, to conceive, create, design or develop any products that will compete with the Producing Party or to harm the outside financial interests of the Producing Party. The provisions disclosed in Paragraph 6 also apply to information and documents designated as AEO HIGHLY CONFIDENTIAL.”

8. The Parties agree that all Confidential Information produced in this Action shall be used by the Receiving Party solely for purposes of the prosecution or defense of this Action and in any appeals of the foregoing. Nothing in this Stipulation and Order shall be construed to limit in any way any Party's use of its own Confidential Information, nor shall it affect any person's or entity's subsequent waiver of its own prior designation with respect to its own Confidential Information.

9. All Confidential Information filed with the Court, and all portions of pleadings, motions or other papers filed with the Court that disclose such Confidential Information shall be filed under seal to the extent permitted by law (including, without limitation any applicable rules of court). To the extent that the Court requires any further act by the Parties as a precondition to the filing of documents under seal (beyond the submission of this Stipulation and Order), it shall be the obligation of the Producing Party of the documents to be filed with the Court to satisfy any such preconditions.

10. Any Receiving Party who objects to any designation of confidentiality may at any time serve upon counsel for the Producing Party a written notice stating with particularity the grounds of the objection. Thereafter, the Parties must confer in good faith regarding such designations. If agreement cannot be reached within five (5) days of the receipt of the written notice, counsel for the Receiving Party may seek a ruling from the Court that such Discovery Material should not be treated as “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL” provided that the burden shall be on the Producing Party to justify the claim that the disputed Discovery Material has been properly designated. The designation of Discovery Material as “CONFIDENTIAL” or “AEO HIGHLY CONFIDENTIAL” shall remain in full force and effect until the dispute is resolved by agreement of the parties or ruled upon by the Court.

11. Subject to Paragraph 10 hereof, this Stipulation and Order shall not apply to the treatment to be given at any trial or evidentiary hearing to any Confidential Discovery Material. Such treatment shall be subject to subsequent order of this Court issued prior to trial.

12. Each person who has access to Confidential Information shall take reasonable precautions to prevent the unauthorized disclosure of such Confidential Information.

13. This Stipulation and Order shall survive the termination of all proceedings in connection with this Action. Within thirty (30) days of the final disposition of this Action (including any appellate proceedings), all Confidential Information and all copies thereof, shall be promptly returned to the Producing Party, or, upon permission of the Producing Party, destroyed. If a Receiving Party chooses to destroy, rather than return, all Confidential Information it shall provide a certification of such destruction to the Producing Party's counsel within thirty (30) days of the final disposition of all proceedings in this Action and written request therefor. With regard to Confidential Information that has been received electronically and that cannot be returned or destroyed, the Receiving Party must take reasonable measures to ensure that (i) the documents are electronically deleted, including from “trash” files and (ii) unauthorized persons do not have access to Confidential Information resident on the recipient's computer server and back-up media. A Party disposing of Confidential Information in a manner consistent with the immediately preceding sentence shall provide a certification of such disposition to the Producing Party's counsel within thirty (30) days of final disposition of proceedings in this Action and written request therefor.

14. If any Receiving Party is subpoenaed in another action or proceeding or served with a document demand, and such subpoena or document demand seeks Confidential Information, the Receiving Party shall give written notice by hand or overnight delivery promptly, and in no event later than five (5) business days after receipt of such subpoena or document demand, to the

Producing Party that identifies the Confidential Information sought and encloses a copy of the subpoena or discovery request. Except as ordered otherwise by a court of competent jurisdiction, the Receiving Party shall refrain from producing any Confidential Information in response to such a subpoena or document demand until the earlier of (i) receipt of written notice from the Producing Party that such party does not object to production of the Confidential Information or (ii) resolution of any timely objection asserted by the Producing Party either by agreement or by order of the court with jurisdiction over the objection of the Producing Party. The burden of opposing the enforcement of the subpoena shall fall solely upon the Producing Party. Nothing herein shall be construed as requiring the Receiving Party or anyone else covered by this Stipulation and Order to challenge or appeal any order directing production of Confidential Information covered by this Stipulation and Order, or to subject himself, herself or itself to any penalties for non-compliance with any legal process or order, or to seek any relief from this Court.

15. A person or entity from whom discovery is sought, or enters an appearance in this Action may join this Stipulation and Order, thereby becoming an additional Party hereto, by executing and filing a Joinder agreeing to be bound by the terms and provisions of this Stipulation and Order.

16. A Party needing relief from the provisions of this Stipulation and Order, or who seeks modification of the Stipulation and Order may, if agreement between or among the Parties cannot be reached, seek appropriate relief from the Court upon notice to the other Parties.

17. Nothing contained in this Stipulation and Order will be construed as: (i) a waiver by a Party of its right to object to any discovery request propounded; (ii) a waiver of any privilege or protection available under the controlling law; or (iii) a waiver of any Party's right to object to the admissibility at trial of any document, testimony or other evidence.

18. This Court shall retain jurisdiction over all persons subject to this Stipulation and Order to the extent necessary to enforce any obligations arising hereunder or to impose sanctions for any contempt thereof.

SO ORDERED.

NON-DISLOSURE AGREEMENT

I, __, acknowledge that I have read and understand the Protective Order in this action governing the non-disclosure of those portions of Discovery Material that have been designated as “Confidential” or “Attorneys Eyes Only -Highly Confidential” (collectively, “Protected Discovery Material”). I agree that I will not disclose such Protected Discovery Material to anyone other than as expressly permitted under the Protective Order. I further agree that I will not use any Discovery Material for any purposes other than for the purposes of this Action as defined in the Protective Order and that, at the conclusion of the Action, I will return all Discovery Material to the Party or attorney from whom I received it. By acknowledging these obligations under the Protective Order, I understand that I am submitting myself to the jurisdiction of the United States District Court for the Eastern Southern District of New York for the purpose of any issue or dispute arising hereunder and that my willful violation of any term of the Protective Order could subject me to punishment for contempt of Court.


Summaries of

Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Co.

United States District Court, Southern District of New York
Jun 28, 2021
Civil Action 21-CV-1025 (PGG)(SLC) (S.D.N.Y. Jun. 28, 2021)
Case details for

Primed Pharmaceuticals LLC v. Starr Indemnity & Liability Co.

Case Details

Full title:PRIMED PHARMACEUTICALS, LLC., Plaintiff, v. STARR INDEMNITY & LIABILITY…

Court:United States District Court, Southern District of New York

Date published: Jun 28, 2021

Citations

Civil Action 21-CV-1025 (PGG)(SLC) (S.D.N.Y. Jun. 28, 2021)